相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Survival Outcomes of Patients With Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis
Ning Li et al.
FRONTIERS IN ONCOLOGY (2022)
Estimation of zorifertinib metabolic stability in human liver microsomes using LC-MS/MS
Mohamed W. Attwa et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2022)
Metabolic Stability Assessment of New PARP Inhibitor Talazoparib Using Validated LC-MS/MS Methodology: In silico Metabolic Vulnerability and Toxicity Studies
Mohamed W. Attwa et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2020)
Reactive intermediates and bioactivation pathways characterization of avitinib by LC-MS/MS: In vitro metabolic investigation
Mohamed W. Attwa et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2019)
Computational methods and tools to predict cytochrome P450 metabolism for drug discovery
Jonathan D. Tyzack et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2019)
WhichP450: a multi-class categorical model to predict the major metabolising CYP450 isoform for a compound
Peter A. Hunt et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2018)
LC-ESI-MS/MS reveals the formation of reactive intermediates in brigatinib metabolism: elucidation of bioactivation pathways
Adnan A. Kadi et al.
RSC ADVANCES (2018)
Identification and characterization of in vivo, in vitro and reactive metabolites of vandetanib using LC-ESI-MS/MS
Mohamed W. Attwa et al.
CHEMISTRY CENTRAL JOURNAL (2018)
LC-MS/MS reveals the formation of iminium and quinone methide reactive intermediates in entrectinib metabolism: In vivo and in vitro metabolic investigation
Mohamed W. Attwa et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2018)
Determination and pharmacokinetic study of AZD-3759 in rat plasma by ultra performance liquid chromatography with triple quadrupole mass spectrometer
Qingjun Wu et al.
THORACIC CANCER (2018)
LC-MS/MS reveals the formation of aldehydes and iminium reactive intermediates in foretinib metabolism: phase I metabolic profiling
Adnan A. Kadi et al.
RSC ADVANCES (2017)
Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study
Myung-Ju Ahn et al.
LANCET RESPIRATORY MEDICINE (2017)
Simultaneous determination of newly developed antiviral agents in pharmaceutical formulations by HPLC-DAD
Nourah Zoman Al-Zoman et al.
CHEMISTRY CENTRAL JOURNAL (2017)
Fragmentation reactions using electrospray ionization mass spectrometry: an important tool for the structural elucidation and characterization of synthetic and natural products
Daniel P. Demarque et al.
NATURAL PRODUCT REPORTS (2016)
Detection and characterization of ponatinib reactive metabolites by liquid chromatography tandem mass spectrometry and elucidation of bioactivation pathways
Adnan A. Kadi et al.
RSC ADVANCES (2016)
Modeling Reactivity to Biological Macromolecules with a Deep Multitask Network
Tyler B. Hughes et al.
ACS CENTRAL SCIENCE (2016)
Site of Reactivity Models Predict Molecular Reactivity of Diverse Chemicals with Glutathione
Tyler B. Hughes et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2015)
Discovery and Evaluation of Clinical Candidate AZD3759, a Potent, Oral Active, Central Nervous System-Penetrant, Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
Qingbei Zeng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Determination of EGFR and KRAS mutational status in Greek non-small-cell lung cancer patients
Eirini Papadopoulou et al.
ONCOLOGY LETTERS (2015)
Defining the Role of Tyrosine Kinase Inhibitors in Early Stage Non-Small Cell Lung Cancer
Sofia Lampaki et al.
JOURNAL OF CANCER (2015)
Epidermal Growth Factor and Epidermal Growth Factor Receptor: The Yin and Yang in the Treatment of Cutaneous Wounds and Cancer
Richard J. Bodnar
ADVANCES IN WOUND CARE (2013)
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
Julian R. Molina et al.
MAYO CLINIC PROCEEDINGS (2012)
Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States
Antonia F. Stepan et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2011)
Profiling the Reactive Metabolites of Xenobiotics Using Metabolomic Technologies
Feng Li et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2011)
Recent advances in applications of liquid chromatography-tandem mass spectrometry to the ana lysis of reactive drug metabolites
Shuguang Ma et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2009)
Liquid chromatography-mass spectrometry in in vitro drug metabolite screening
Ari Tolonen et al.
DRUG DISCOVERY TODAY (2009)
Radical cations in electrospray mass spectrometry:: Formation of open-shell species, examination of the fragmentation behaviour in ESI-MSn and reaction mechanism studies by detection of transient radical cations
Mathias Schaefer et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2007)
Biology of interactions: Antiepidermal growth factor receptor agents
Paul M. Harari et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Structure elucidation of phase II metabolites by tandem mass spectrometry:: an overview
K Levsen et al.
JOURNAL OF CHROMATOGRAPHY A (2005)
Profiling of sulfoconjugates in urine by using precursor ion and neutral loss scans in tandem mass spectrometry. Application to the investigation of heavy metal toxicity in rats
A Lafaye et al.
JOURNAL OF MASS SPECTROMETRY (2004)
分享论文
